NDC 0703-4502-01 - Metoclopramide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0703-4502
- Requested NDC
- 0703-4502-01
- Package NDCs from labels
- 0703-4502-01, 0703-4502-04, 0703-4502-91, 0703-4502-93, 0703-4502-81, 0703-4502-84
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-09-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoclopramide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-09-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide Injection, USP Rx only | Teva Parenteral Medicines, Inc. | 2026-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide Injection, USP Rx only | Teva Parenteral Medicines, Inc. | 2026-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2020-01-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide Injection USP 4502 Rx only | Teva Parenteral Medicines, Inc. | 2015-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0703-4502-01 | Metoclopramide | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | 14 | |
| 0703-4502-04 | Metoclopramide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 14 | |
| 0703-4502-91 | Metoclopramide | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | 8 | |
| 0703-4502-93 | Metoclopramide | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0703-4502 | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 13 | Current NDC, Legacy NDC, 2 package rows | 20230628_cccf04bd-7463-40b8-a41f-cb1093c358d7.zip |
| 0703-4502 | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20240906_5645a752-8868-4b51-8b59-48bb4276d763.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0703-4502-01 | ML - Milliliter | 0703-4502 | 3c2e19db-3873-43d2-9b74-efb5910a9860 | 1 | 2014-02-04 |
| 0703-4502-04 | ML - Milliliter | 0703-4502 | 970d311d-0e29-4d91-9b8a-561465ea9a7a | 1 | 2014-01-04 |
| 0703-4502-81 | ML - Milliliter | 0703-4502 | d8a195ab-53f6-411d-a01e-45b69b4e4f51 | 1 | 2015-09-10 |
| 0703-4502-84 | ML - Milliliter | 0703-4502 | b74cc0a4-bfb8-499f-90fb-225c8939f713 | 1 | 2015-09-10 |
| 0703-4502-91 | ML - Milliliter | 0703-4502 | c422a339-78a6-4e65-9e5c-d13779f4857a | 1 | 2015-03-03 |
| 0703-4502-93 | ML - Milliliter | 0703-4502 | 6e09e861-5b9d-4052-a6bd-5b708539b004 | 1 | 2024-10-04 |
| 0703-4502-94 | ML - Milliliter | 0703-4502 | fdf9c277-d402-40d7-a220-a842ac3bfbad | 1 | 2015-03-03 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| Metoclopramide | METOCLOPRAMIDE | REMEDYREPACK INC. | 5d31d815-50fa-4e78-8ebd-affc2514ce78 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Metoclopramide | METOCLOPRAMIDE | American Health Packaging | 0034a97a-fb05-418a-a234-de278907cd2a | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-07-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Metoclopramide | METOCLOPRAMIDE | Ipca Laboratories Limited | c143e210-4ce7-44e5-b1e2-bf0e6bfde485 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | ATLANTIC BIOLOGICALS CORP. | 3cd4b274-6176-4e5b-9765-4f50763bd58f | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Protective Industrial Products, Inc. | 558e5926-9027-d3f6-e063-6294a90ab121 | 2026-07-02 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.